France Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery

GlobalData
141 Pages - GLDATA57709
$5,995.00

Summary

GlobalData’s new report, "France Diabetes Care Devices Market Outlook to 2022", provides key market data on the France Diabetes Care Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Glucose Monitoring and Insulin Delivery.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Diabetes Care Devices market categories - Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2008 to 2015 and forecast to 2022.
- 2015 company shares and distribution shares data for Diabetes Care Devices market.
- Global corporate-level profiles of key companies operating within the France Diabetes Care Devices market.
- Key players covered include LifeScan Inc, Medtronic plc, Bayer HealthCare AG, F. Hoffmann-La Roche Ltd and others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned

Sanofi
F. Hoffmann-La Roche Ltd
LifeScan Inc
Bayer HealthCare AG
Eli Lilly and Company
Abbott Laboratories
Medtronic plc
Novo Nordisk A/S
Ypsomed Holding AG
Becton Dickinson and Co
Arkray Inc

'

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 8
2.1 What Is This Report About? 8
2.2 Diabetes Care Devices Market Segmentation 8
2.3 Definitions of Markets Covered in the Report 9
3 Diabetes Care Devices Market, France 11
3.1 Diabetes Care Devices Market, France, Revenue ($m), 2008-2022 11
3.2 Diabetes Care Devices Market, France, Revenue Mix ($m), 2015 12
3.3 Diabetes Care Devices Market, France, Category Contribution by Revenue ($m), 2015 13
3.4 Diabetes Care Devices Market, France, Revenue ($m), 2008-2015 14
3.5 Diabetes Care Devices Market, France, Revenue ($m), 2015-2022 16
3.6 Diabetes Care Devices Market, France, Volume (Units), 2008-2022 18
3.7 Diabetes Care Devices Market, France, Volume (Units), 2008-2015 19
3.8 Diabetes Care Devices Market, France, Volume (Units), 2015-2022 21
3.9 Diabetes Care Devices Market, France, Company Share by Revenue ($m), 2015 23
4 Glucose Monitoring Market, France 25
4.1 Glucose Monitoring Market, France, Revenue Mix ($m), 2015 25
4.2 Glucose Monitoring Market, France, Segment Contribution (%), 2015 26
4.3 Glucose Monitoring Market, France, Revenue ($m), 2008-2015 27
4.4 Glucose Monitoring Market, France, Revenue ($m), 2015-2022 29
4.4.1 Blood Glucose Meters Market, France, Revenue ($m), by Segment, 2008-2015 31
4.4.2 Blood Glucose Meters Market, France, Revenue ($m), by Segment, 2015-2022 33
4.5 Glucose Monitoring Market, France, Volume (Units), 2008-2015 35
4.6 Glucose Monitoring Market, France, Volume (Units), 2015-2022 37
4.6.1 Blood Glucose Meters Market, France, Volume (Units), by Segment, 2008-2015 39
4.6.2 Blood Glucose Meters Market, France, Volume (Units), by Segment, 2015-2022 41
4.7 Glucose Monitoring Market, France, Distribution Share by Revenue ($m), 2014-2015 43
4.8 Glucose Monitoring Market, France, Company Share by Revenue ($m), 2015 44
5 Insulin Delivery Market, France 46
5.1 Insulin Delivery Market, France, Revenue Mix ($m), 2015 46
5.2 Insulin Delivery Market, France, Segment Contribution (%), 2015 47
5.3 Insulin Delivery Market, France, Revenue ($m), 2008-2015 48
5.4 Insulin Delivery Market, France, Revenue ($m), 2015-2022 50
5.4.1 Insulin Pens Market, France, Revenue ($m), by Segment, 2008-2015 52
5.4.2 Insulin Pumps Market, France, Revenue ($m), by Segment, 2008-2015 54
5.4.3 Insulin Pens Market, France, Revenue ($m), by Segment, 2015-2022 55
5.4.4 Insulin Pumps Market, France, Revenue ($m), by Segment, 2015-2022 57
5.5 Insulin Delivery Market, France, Volume (Units), 2008-2015 59
5.6 Insulin Delivery Market, France, Volume (Units), 2015-2022 61
5.6.1 Insulin Pens Market, France, Volume (Units), by Segment, 2008-2015 63
5.6.2 Insulin Pumps Market, France, Volume (Units), by Segment, 2008-2015 65
5.6.3 Insulin Pens Market, France, Volume (Units), by Segment, 2015-2022 66
5.6.4 Insulin Pumps Market, France, Volume (Units), by Segment, 2015-2022 68
5.7 Insulin Delivery Market, France, Distribution Share by Revenue ($m), 2014-2015 70
5.8 Insulin Delivery Market, France, Company Share by Revenue ($m), 2015 71
6 Overview of Key Companies in France, Diabetes Care Devices Market 73
6.1 Sanofi 73
6.1.1 Company Overview 73
6.2 F. Hoffmann-La Roche Ltd 73
6.2.1 Company Overview 73
6.3 LifeScan Inc 73
6.3.1 Company Overview 73
6.4 Bayer HealthCare AG 73
6.4.1 Company Overview 73
6.5 Eli Lilly and Company 74
6.5.1 Company Overview 74
6.6 Abbott Laboratories 74
6.6.1 Company Overview 74
6.7 Medtronic plc 74
6.7.1 Company Overview 74
6.8 Novo Nordisk A/S 75
6.8.1 Company Overview 75
6.9 Ypsomed Holding AG 75
6.9.1 Company Overview 75
6.10 Becton Dickinson and Co 75
6.10.1 Company Overview 75
6.11 Arkray Inc 76
6.11.1 Company Overview 76
7 Diabetes Care Devices Market Pipeline Products 77
8 Financial Deals Landscape 78
8.1 Equity Offerings 78
8.1.1 Defymed Receives Investment from JDRF 78
8.2 Partnerships 79
8.2.1 Defymed Enters into Agreement with Semma Therapeutics 79
8.2.2 Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies 80
8.2.3 Senseonics Amends its Distribution Agreement with F. Hoffmann-La Roche 81
8.2.4 Medtronic and Qualcomm Life Enter into Co-Development Agreement 82
8.2.5 Metabolon Enters into Licensing Agreement with Synlab 83
8.2.6 Cellnovo Enters into Agreement with Roche Diagnostics 84
9 Recent Developments 85
9.1 Corporate Communications 85
9.1.1 Sep 30, 2016: Sanofi Appoints Alan Main to Executive Committee and Executive Vice President, Consumer Healthcare 85
9.1.2 Sep 07, 2016: Sanofi Appoints New Research Head for Immunology and Inflammation 85
9.1.3 Sep 06, 2016: Sanofi Board Of Directors Provides Update 86
9.1.4 Aug 15, 2016: MMJ PhytoTech to Commence Phase 2 Clinical Trial on Pediatric Epilepsy 86
9.1.5 May 23, 2016: Sanofi Announces Changes to Executive Committee Aligned to its Strategic Roadmap 2020 87
9.1.6 May 05, 2016: Encore Vision Announces Successful Phase I-II Study of Topical EV06 for the Treatment of Presbyopia 88
9.1.7 Mar 29, 2016: Sanofi Appoints Dr. Yong-Jun Liu as Head of Research 90
9.1.8 Mar 10, 2016: Sanofi Appoints Dr. Ameet Nathwani to Executive Committee and Executive Vice President, Group Chief Medical Officer 90
9.2 Financial Announcements 91
9.2.1 Oct 28, 2016: Sanofi Announces Strong Q3 2016 Results 91
9.2.2 Aug 16, 2016: vTv Therapeutics Completes Enrollment of Phase 2 Trial Evaluating TTP273 for the Treatment of Type 2 Diabetes 98
9.2.3 Aug 16, 2016: OncoGenex Announced Results from the Phase 3 AFFINITY Trial of Custirsen in Men with Metastatic Castrate-Resistant Prostate Cancer 100
9.2.4 Jul 29, 2016: Sanofi Announces Q2 2016 Results 102
9.2.5 Jul 29, 2016: Royalty report for Q2 2016 and update on lixisenatide (Lyxumia/Adlyxin) and iGlarLixi 110
9.2.6 Apr 29, 2016: Solid Performance in the First Quarter of 2016 with Business EPS up 5.3% at Constant Exchange Rates 111
9.2.7 Mar 14, 2016: Chiasma Initiates Phase 3 Trial to Support European Registration of Octreotide Capsules for Patients with Acromegaly 118
9.2.8 Feb 09, 2016: Sanofi Delivered 2015 Business EPS Up 8.5% On A Reported Basis And Stable At Constant Exchange Rates Consistent With Guidance 121
9.3 Government and Public Interest 129
9.3.1 Jun 13, 2016: Sanofi Files Definitive Consent Solicitation To Remove And Replace Medivation’s Board 129
9.3.2 Jun 01, 2016: Sanofi Requests Record Date for Consent Solicitation to Remove and Replace Medivation’s Board of Directors 130
9.4 Other Significant Developments 130
9.4.1 May 25, 2016: Sanofi Files Consent Solicitation To Remove and Replace Medivation’s Board 130
9.4.2 Apr 19, 2016: Sanofi Invests €300 Million To Expand Biologics Site in Belgium 134
9.4.3 Apr 19, 2016: Sanofi Invests €300 Million in its Biologics Site in Belgium to Develop its Monoclonal Antibodies Portfolio 134
9.5 Strategy And Business Planning 135
9.5.1 Jul 05, 2016: Sanofi Enters Into Confidentiality Agreement With Medivation And Will Be Provided Due Diligence Access And Confidential Information 135
9.5.2 Apr 19, 2016: Sanofi Invests €300 Million To Expand Biologics Site in Belgium 136
10 Appendix 137
10.1 Research Methodology 138
10.1.1 Coverage 138
10.1.2 Secondary Research 138
10.1.3 Primary Research 139
10.1.4 Company Share Analysis 139
10.1.5 Distribution Share Analysis 139
10.1.6 Benchmarking 140
10.2 GlobalData Consulting 140
10.3 Contact Us 140
10.4 Disclaimer 141

1.1 List of Tables
Table 1: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, 2008-2022 11
Table 2: Diabetes Care Devices Market, France, Category Contribution by Revenue ($m), 2015 13
Table 3: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, Historic, 2008-2015 15
Table 4: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022 17
Table 5: Diabetes Care Devices Market, France, Volume (Units), 2008-2022 18
Table 6: Diabetes Care Devices Market, France, Volume (Units), Historic, 2008-2015 20
Table 7: Diabetes Care Devices Market, France, Volume (Units), Forecast, 2015-2022 22
Table 8: Diabetes Care Devices Market, France, Company Share by Revenue ($m), USD Constant, 2015 24
Table 9: Glucose Monitoring Market, France, Segment Contribution (%), 2015 26
Table 10: Glucose Monitoring Market, France, Revenue ($m), USD Constant, Historic, 2008-2015 28
Table 11: Glucose Monitoring Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022 30
Table 12: Blood Glucose Meters Market, France, Revenue ($m), USD Constant, Historic, 2008-2015 32
Table 13: Blood Glucose Meters Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022 34
Table 14: Glucose Monitoring Market, France, Volume (Units), Historic, 2008-2015 36
Table 15: Glucose Monitoring Market, France, Volume (Units), Forecast, 2015-2022 38
Table 16: Blood Glucose Meters Market, France, Volume (Units), Historic, 2008-2015 40
Table 17: Blood Glucose Meters Market, France, Volume (Units), Forecast, 2015-2022 42
Table 18: Glucose Monitoring Market, France, Distribution Share by Revenue ($m), USD Constant, 2014-2015 43
Table 19: Glucose Monitoring Market, France, Company Share by Revenue ($m), USD Constant, 2015 45
Table 20: Insulin Delivery Market, France, Segment Contribution (%), 2015 47
Table 21: Insulin Delivery Market, France, Revenue ($m), USD Constant, Historic, 2008-2015 49
Table 22: Insulin Delivery Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022 51
Table 23: Insulin Pens Market, France, Revenue ($m), USD Constant, Historic, 2008-2015 53
Table 24: Insulin Pumps Market, France, Revenue ($m), USD Constant, Historic, 2008-2015 54
Table 25: Insulin Pens Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022 56
Table 26: Insulin Pumps Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022 58
Table 27: Insulin Delivery Market, France, Volume (Units), Historic, 2008-2015 60
Table 28: Insulin Delivery Market, France, Volume (Units), Forecast, 2015-2022 62
Table 29: Insulin Pens Market, France, Volume (Units), Historic, 2008-2015 64
Table 30: Insulin Pumps Market, France, Volume (Units), Historic, 2008-2015 65
Table 31: Insulin Pens Market, France, Volume (Units), Forecast, 2015-2022 67
Table 32: Insulin Pumps Market, France, Volume (Units), Forecast, 2015-2022 69
Table 33: Insulin Delivery Market, France, Distribution Share by Revenue ($m), USD Constant, 2014-2015 70
Table 34: Insulin Delivery Market, France, Company Share by Revenue ($m), USD Constant, 2015 72
Table 35: Diabetes Care Devices Market Pipeline Products 77
Table 36: Defymed Receives Investment from JDRF 78
Table 37: Defymed Enters into Agreement with Semma Therapeutics 79
Table 38: Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies 80
Table 39: Senseonics Amends its Distribution Agreement with F. Hoffmann-La Roche 81
Table 40: Medtronic and Qualcomm Life Enter into Co-Development Agreement 82
Table 41: Metabolon Enters into Licensing Agreement with Synlab 83
Table 42: Cellnovo Enters into Agreement with Roche Diagnostics 84

1.2 List of Figures
Figure 1: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, 2008-2022 11
Figure 2: Diabetes Care Devices Market, France, Revenue Mix ($m), 2015 12
Figure 3: Diabetes Care Devices Market, France, Category Contribution (%), 2015 13
Figure 4: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, Historic, 2008-2015 14
Figure 5: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022 16
Figure 6: Diabetes Care Devices Market, France, Volume (Units), 2008-2022 18
Figure 7: Diabetes Care Devices Market, France, Volume (Units), Historic, 2008-2015 19
Figure 8: Diabetes Care Devices Market, France, Volume (Units), Forecast, 2015-2022 21
Figure 9: Diabetes Care Devices Market, France, Company Share (%) 2015 23
Figure 10: Glucose Monitoring Market, France, Revenue Mix ($m), 2015 25
Figure 11: Glucose Monitoring Market, France, Segment Contribution (%), 2015 26
Figure 12: Glucose Monitoring Market, France, Revenue ($m), USD Constant, Historic, 2008-2015 27
Figure 13: Glucose Monitoring Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022 29
Figure 14: Blood Glucose Meters Market, France, Revenue ($m), USD Constant, Historic, 2008-2015 31
Figure 15: Blood Glucose Meters Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022 33
Figure 16: Glucose Monitoring Market, France, Volume (Units), Historic, 2008-2015 35
Figure 17: Glucose Monitoring Market, France, Volume (Units), Forecast, 2015-2022 37
Figure 18: Blood Glucose Meters Market, France, Volume (Units), Historic, 2008-2015 39
Figure 19: Blood Glucose Meters Market, France, Volume (Units), Forecast, 2015-2022 41
Figure 20: Glucose Monitoring Market, France, Company Share (%) 2015 44
Figure 21: Insulin Delivery Market, France, Revenue Mix ($m), 2015 46
Figure 22: Insulin Delivery Market, France, Segment Contribution (%), 2015 47
Figure 23: Insulin Delivery Market, France, Revenue ($m), USD Constant, Historic, 2008-2015 48
Figure 24: Insulin Delivery Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022 50
Figure 25: Insulin Pens Market, France, Revenue ($m), USD Constant, Historic, 2008-2015 52
Figure 26: Insulin Pumps Market, France, Revenue ($m), USD Constant, Historic, 2008-2015 54
Figure 27: Insulin Pens Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022 55
Figure 28: Insulin Pumps Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022 57
Figure 29: Insulin Delivery Market, France, Volume (Units), Historic, 2008-2015 59
Figure 30: Insulin Delivery Market, France, Volume (Units), Forecast, 2015-2022 61
Figure 31: Insulin Pens Market, France, Volume (Units), Historic, 2008-2015 63
Figure 32: Insulin Pumps Market, France, Volume (Units), Historic, 2008-2015 65
Figure 33: Insulin Pens Market, France, Volume (Units), Forecast, 2015-2022 66
Figure 34: Insulin Pumps Market, France, Volume (Units), Forecast, 2015-2022 68
Figure 35: Insulin Delivery Market, France, Company Share (%) 2015 71

$5,995.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports